An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li1, Lan-Ping Xu1, Yu Wang1

  • 1Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.

Blood
|May 25, 2022
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos